MC
CMD

Menta Capital’s Cantel Medical Corporation CMD Stock Holding History

Menta Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,100
Closed -$351K – 1014
2016
Q2 		$351K Buy
+5,100
New +$352K 0.05% 633

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Menta Capital's CMD Position: Q3 2016 in Review

Menta Capital sold out of Cantel Medical Corporation (CMD) in Q3 2016, closing a stake of 5,100 shares — an estimated $351K sold.

Menta Capital first reported a position in CMD in Q2 2016 and held it in 1 quarter. The position peaked at $351K in Q2 2016. 227 funds tracked by Wall St. Rank hold CMD as of Q3 2016.

  • Menta Capital reported no remaining Cantel Medical Corporation position as of Q3 2016 after selling out during the quarter.
  • Menta Capital sold 5,100 Cantel Medical Corporation shares in Q3 2016, an estimated $351K.
  • Menta Capital first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 1 quarter.
  • Menta Capital's Cantel Medical Corporation position peaked at $351K in Q2 2016.
  • 227 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2016.

Based on Menta Capital's 13F filing for Q3 2016, filed 14 Nov 2016.